Published January 13, 2022 | By Hemp Industry Daily staff
More research saying cannabinoids may protect human cells from COVID-19 was released this week from scientists in Ontario working with synthetic CBD.
Researchers at the University of Waterloo reported in a pre-peer-reviewed study that the synthetic CBD “appears to prime the innate immune system of cells, potentially offering protection against pathogens such as SARS-CoV-2,” the virus that causes COVID-19 illness.
Coupled with an Oregon State University announcement that two hemp cannabinoids may protect human cells from SARS-CoV-2, the University of Waterloo research lends additional firepower to CBD manufacturers who have long had to rely on anecdotal evidence more than academic studies to argue for the plant’s medicinal value. Synthetic CBD works by augmenting the anti-viral response of cells to three key proteins produced by the SARS-CoV-2 genome, the Waterloo scientists concluded.